As mentioned above, individuals with T1D often have obesity rates comparable to their age-matched peers at diagnosis and are at risk for further weight gain due to systemic insulin therapy, frequent snacking to manage hypoglycemia, and reduced physical activity (48–50). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.